Hybrid Coronary Revascularization has Improved Short-term Outcomes but Worse Mid-term Reintervention Rates Compared

Yu Xia1, Abraham N Katz, Stephen J Forest

  • 1From the *Department of Cardiothoracic and Vascular Surgery, and †Division of Cardiology, Department of Medicine, Montefiore Medical Center, Bronx, NY USA.

Insights

Hybrid coronary revascularization offers better short-term outcomes than conventional bypass grafting, with similar survival rates. However, patients undergoing hybrid procedures may require reintervention sooner.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Medical Technology Assessment

Background:

  • Multivessel coronary artery disease requires effective revascularization strategies.
  • Hybrid coronary revascularization (HCR) combines surgical and percutaneous approaches.
  • Conventional coronary artery bypass grafting (CABG) is a standard treatment.

Purpose of the Study:

  • To compare short-term outcomes and mid-term survival between HCR and CABG.
  • To evaluate reintervention rates in patients undergoing HCR versus CABG.
  • To utilize a propensity score-matched cohort for robust comparison.

Main Methods:

  • Retrospective review of patients with multivessel coronary artery disease (2007-2015).
  • Propensity score matching (1:1) of HCR and CABG patients based on preoperative characteristics.
  • Comparison of short-term outcomes, 30-day mortality, readmission, and mid-term survival using Kaplan-Meier and Cox regression.

Main Results:

  • HCR group showed shorter postoperative length of stay (4 vs 5 days) and less transfusion.
  • Higher discharge home rate (93.4% vs 71.4%) in HCR group.
  • No significant difference in 30-day mortality or mid-term survival; HCR associated with earlier reintervention (HR 3.60).

Conclusions:

  • HCR demonstrates favorable short-term outcomes and similar survival to CABG.
  • HCR may be associated with an increased likelihood of earlier reintervention.
  • Careful patient selection and follow-up are crucial for HCR.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
346
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
347
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551